Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Director/PDMR Shareholding

10 Dec 2008 10:00

RNS Number : 8620J
Flying Brands Limited
10 December 2008
 



SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS

1) 

Name of company

 

Flying Brands Limited

2)

Name of director

 

F G Voisin

3) 

Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial interest

 

As above

4) 

Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)

N/A

5) 

Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)

 

N/A

6) 

Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary

 

N/A

7)

Number of shares/amount of stock acquired

 

15,000

8)

Percentage of issued class

 

0.06%

9)

Number of shares/amount of stock disposed

 

N/A

10)

Percentage of issued class

 

N/A

11)

Class of security

 

Units (comprising ordinary shares of 1 pence each and A ordinary shares of 0.005 pence each)

12)

Price per share

 

£0.35

13)

Date of transaction

 

8 December 2008

14) 

Date company informed

 

9 December 2008

15)

Total holding following this notification

 

15,000

16)

Total percentage holding of issued class following this notification

 

0.06%

If a director has been granted options by the company please complete the following boxes

17)

Date of grant

 

 N/A

18)

Period during which or date on which exercisable

 

 N/A

19)

Total amount paid (if any) for grant of the option

 

 N/A

20)

Description of shares or debentures involved: class, number

 

 N/A

21)

Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise

 

 N/A

22)

Total number of shares or debentures over which options held following this notification

 

 N/A

23)

Any additional information

 

 N/A

24)

Name of contact and telephone number for queries

 

Graham Norton 01245228300

25)

Name and signature of authorised company official responsible for making this notification

 

Graham Norton - Finance Director

Date of Notification

10 December 2008

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFFMSUSSASEEE
Date   Source Headline
2nd Sep 20217:00 amRNSBoard Changes
1st Sep 202110:00 amRNSStart of Trading on the OTCQB Venture Market
27th Aug 20219:57 amRNSHalf Yearly Report
11th Jun 20214:41 pmRNSSecond Price Monitoring Extn
11th Jun 20214:36 pmRNSPrice Monitoring Extension
11th Jun 20212:05 pmRNSSecond Price Monitoring Extn
11th Jun 20212:00 pmRNSPrice Monitoring Extension
11th Jun 202111:05 amRNSSecond Price Monitoring Extn
11th Jun 202111:00 amRNSPrice Monitoring Extension
11th Jun 20218:00 amRNSIQAI Awarded “Gad-Free” Patent
4th Jun 20217:00 amRNSIB Software Chosen by LA County Hospital
19th May 202112:06 pmRNSResult of AGM
27th Apr 20213:27 pmRNSNotice of AGM
20th Apr 202110:21 amRNSFinal Results
16th Apr 20214:41 pmRNSSecond Price Monitoring Extn
16th Apr 20214:36 pmRNSPrice Monitoring Extension
13th Apr 20217:27 amRNSIQAI commits to Phase 1 study
6th Apr 20217:00 amRNSFive Year NCI Award Grant to IB
5th Feb 20214:41 pmRNSSecond Price Monitoring Extn
5th Feb 20214:36 pmRNSPrice Monitoring Extension
5th Feb 20212:05 pmRNSSecond Price Monitoring Extn
5th Feb 20212:01 pmRNSPrice Monitoring Extension
5th Feb 20219:05 amRNSSecond Price Monitoring Extn
5th Feb 20219:00 amRNSPrice Monitoring Extension
28th Jan 20217:00 amRNS"Gad Free" Imaging Update
25th Jan 202111:01 amRNSPrice Monitoring Extension
14th Jan 20217:00 amRNSTechnology Portfolio Update
7th Jan 20212:06 pmRNSSecond Price Monitoring Extn
7th Jan 20212:00 pmRNSPrice Monitoring Extension
31st Dec 202012:41 pmRNSSecond Price Monitoring Extn
31st Dec 202012:36 pmRNSPrice Monitoring Extension
31st Dec 202011:00 amRNSPrice Monitoring Extension
10th Dec 202010:41 amRNSDirector Dealing and CLN Conversion - Correction
9th Dec 20202:05 pmRNSSecond Price Monitoring Extn
9th Dec 20202:01 pmRNSPrice Monitoring Extension
9th Dec 20209:02 amRNSDirector Dealing and Conversion of Loan Notes
7th Dec 202011:25 amRNSDirector Dealing
4th Dec 20204:52 pmRNSIssue of shares to Mayo Clinic
3rd Dec 20207:01 amRNSRelease of StoneChecker 20.12
26th Nov 20207:00 amRNSIMAGING BIOMETRICS UPGRADES IB CLINIC™ SOFTWARE
23rd Nov 20204:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20204:36 pmRNSPrice Monitoring Extension
23rd Nov 20202:06 pmRNSSecond Price Monitoring Extn
23rd Nov 20202:00 pmRNSPrice Monitoring Extension
23rd Nov 20201:45 pmRNSLSN Software is now CE Mark Approved
23rd Nov 202011:06 amRNSSecond Price Monitoring Extn
23rd Nov 202011:00 amRNSPrice Monitoring Extension
20th Nov 202011:05 amRNSSecond Price Monitoring Extn
20th Nov 202011:00 amRNSPrice Monitoring Extension
20th Nov 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.